EUVIMEDEUVIMED entdecken
Crossref

Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity

Xujia Lu, Xiaohong Zhu, Guochen Li iD, Luying Wu, Liping Shao, Yulong Fan, Chen-Wei Pan, Ying Wu, Yan Borné, Chaofu Ke iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Xujia Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, School of Public Health, Suzhou Medical College of Soochow University, Suzhou 215123, China. Hauptthemen laut MEDLINE: Caffeine, Coffee, Tea, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Project of MOE Key Laboratory of Geriatric Diseases and Immunology, Research on Key Technologies for the Prevention and Control of Major Diseases and Infectious Diseases in Suzhou.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Cardiometabolic multimorbidity (CM) is an increasing public health concern. Previous observational studies have suggested inverse associations between coffee, tea, and caffeine intake and risks of individual cardiometabolic diseases; however, their associations with CM and related biological markers are unknown.

Methods

This prospective study involved 172 315 (for caffeine analysis) and 188 091 (tea and coffee analysis) participants free of any cardiometabolic diseases at baseline from the UK Biobank; 168 metabolites were measured among 88 204 and 96 393 participants. CM was defined as the coexistence of at least 2 of the following conditions: type 2 diabetes, coronary heart disease, and stroke.

Results

Nonlinear inverse associations of coffee, tea, and caffeine intake with the risk of new-onset CM were observed. Compared with nonconsumers or consumers of less than 100 mg caffeine per day, consumers of moderate amount of coffee (3 drinks/d) or caffeine (200-300 mg/d) had the lowest risk for new-onset CM, with respective hazard ratios (95% CIs) of 0.519 (0.417-0.647) and 0.593 (0.499-0.704). Multistate models revealed that moderate coffee or caffeine intake was inversely associated with risks of almost all developmental stages of CM, including transitions from a disease-free state to single cardiometabolic diseases and subsequently to CM. A total of 80 to 97 metabolites, such as lipid components within very low-density lipoprotein, histidine, and glycoprotein acetyls, were identified to be associated with both coffee, tea, or caffeine intake and incident CM.

Conclusion

Habitual coffee or caffeine intake, especially at a moderate level, was associated with a lower risk of new-onset CM and could play important roles in almost all transition phases of CM development. Future studies are warranted to validate the implicated metabolic biomarkers underlying the relation between coffee, tea, and caffeine intake and CM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CaffeineCoffeeTeaDiabetes Mellitus, Type 2Cardiovascular DiseasesCoronary DiseaseStrokeHumansMaleFemaleMiddle AgedProspective StudiesAgedMultimorbidityUnited KingdomBiomarkersRisk FactorsAdult

Stichwörter der Autor:innen

UK Biobankcaffeinecardiometabolic multimorbiditycoffeeplasma metabolitestea

Substanzen

CaffeineCoffeeTeaBiomarkers

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, School of Public Health, Suzhou Medical College of Soochow University, Suzhou 215123, China.
  • MOE Key Laboratory of Geriatric Diseases and Immunology, Soochow University, Suzhou 215123, Jiangsu, China.
  • Suzhou Centers for Disease Control and Prevention, Suzhou 215000, Jiangsu, China.
  • School of Public Health, Suzhou Medical College of Soochow University, Suzhou 215123, China.
  • Department of Biostatistics, School of Public Health, Southern Medical University, Guangzhou 510515, China.
  • Department of Clinical Sciences Malmö, Lund University, Malmö 20502, Sweden.

ORCID-Profile: Guochen Li, Chaofu Ke

Förderung

  • National Natural Science Foundation of China
  • Project of MOE Key Laboratory of Geriatric Diseases and Immunology
  • Research on Key Technologies for the Prevention and Control of Major Diseases and Infectious Diseases in Suzhou

Zitieren

APA

Lu, X., Zhu, X., Li, G., Wu, L., Shao, L., Fan, Y., Pan, C. W., Wu, Y., Borné, Y., & Ke, C. (2025). Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae552

Vancouver

Lu X, Zhu X, Li G, Wu L, Shao L, Fan Y, et al. Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae552

BibTeX
@article{Lu2025,
  author = {Lu, Xujia and Zhu, Xiaohong and Li, Guochen and Wu, Luying and Shao, Liping and Fan, Yulong and Pan, Chen-Wei and Wu, Ying and Borné, Yan and Ke, Chaofu},
  title = {Habitual Coffee, Tea, and Caffeine Consumption, Circulating Metabolites, and the Risk of Cardiometabolic Multimorbidity},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae552}
}
Kostenlos starten →